Overview

Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)

Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if growth hormone given 4 weeks before as well as during a cycle of in vitro fertilization will improve outcomes in women who have had previous failure with IVF treatment cycles using high doses of follicle stimulating medications and had a poor response (less than 6 follicles).
Phase:
Phase 2
Details
Lead Sponsor:
Ottawa Fertility Centre
Collaborator:
EMD Serono
Treatments:
Chorionic Gonadotropin
Follicle Stimulating Hormone
Hormones